Search
Big molecules - Huge potential | Bioxcellence | Boehringer Ingelheim
Explore the potential of big molecules with BioXcellence, offering advanced biopharmaceutical production services to unlock new possibilities in healthcare.
Monoclonal Antibody Production | Bioxcellence | Boehringer Ingelheim
Explore our advanced capabilities in antibody production, and learn about the unique features of monoclonal & polyclonal antibodies.
Media & News | Bioxcellence | Boehringer Ingelheim
Stay updated with BioXcellence Media & News. Explore the latest industry trends & news in global biopharmaceutical contract manufacturing. Don't miss out!
Partnering in Technologies HP SEPT 2024 CORP_0.pdf
Partnering in Technologies AH MAY 2024 CORP.pdf
Angels SD4G_Infografik_2024 Final (1).pdf
Partnering in Oncology & Cancer Imm HP OCTOBER 2024 CORP.pdf
Partnering in RBB HP OCTOBER CORP.pdf
Partnering in Biotherapeutics HP OCTOBER 2024 CORP_1.pdf
Partnering in Technologies HP OCTOBER 2024 CORP.pdf
Iclepertin: GlyT1 inhibitor
Iclepertin: GlyT1 inhibitor
The ANGELS infographic showcasing global stroke care improvements.pdf
C3-binding polypeptide
C3-binding polypeptide
Global Network | Bioxcellence | Boehringer Ingelheim
Our network of manufacturing facilities spans the globe, from Fremont, in the United States to Biberach in Germany, Vienna in Austria and Shanghai in China
Infographic: ANGELS Initiative
C3-binding polypeptide
Partnering in Mental Health Disorders HP OCTOBER 2024 CORP.pdf
Partnering in Cardio-Renal-Metabolic HP OCTOBER 2024 CORP.pdf
Partnering in Immunology & Resp HP OCTOBER 2024 CORP.pdf
Angels_SD4G_Infografik_2024_Final.pdf
Human Health Partnering Interests
Human Health Partnering Interests
Boehringer Ingelheim - Life Forward
Learn how we change life for the better for people and animals.
Questions and Answers
Answers to common questions from both patients and health care professionals regarding Compassionate Use of experimental medications.
Valerie Nock
My career challengeFunctional Areas at Boehringer Ingelheim